Coty Inc. (COTY) stock
COTYNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends June 30
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 3/3010% above fair value
$4.06−0.27 (-6.24%)
Close on Nov 11, 2026Market cap $3.58BP/E –Yield –
Coty EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Coty's EPS for the twelve months ending Sep 30, 2026 was -$0.65. For fiscal 2026 it was -$0.70. The highest annual figure on record is $0.64 in fiscal 2015.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | -$0.70 | – |
| FY2025 | Jun 30, 2025 | -$0.44 | -588.9% |
| FY2024 | Jun 30, 2024 | $0.09 | -84.2% |
| FY2023 | Jun 30, 2023 | $0.57 | +612.5% |
| FY2022 | Jun 30, 2022 | $0.08 | – |
| FY2021 | Jun 30, 2021 | -$0.40 | – |
| FY2020 | Jun 30, 2020 | -$1.33 | – |
| FY2019 | Jun 30, 2019 | -$5.04 | – |
| FY2018 | Jun 30, 2018 | -$0.23 | – |
| FY2017 | Jun 30, 2017 | -$0.66 | -250.0% |
| FY2016 | Jun 30, 2016 | $0.44 | -31.3% |
| FY2015 | Jun 30, 2015 | $0.64 | – |
| FY2014 | Jun 30, 2014 | -$0.26 | -161.9% |
| FY2013 | Jun 30, 2013 | $0.42 | – |
| FY2012 | Jun 30, 2012 | -$0.87 | – |
Quarterly eps
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $0.12 | +71.4% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | -$0.16 | – |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | -$0.47 | – |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | -$0.14 | -800.0% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $0.07 | -22.2% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | -$0.08 | – |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | -$0.47 | – |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $0.02 | -90.0% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $0.09 | – |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | -$0.11 | -466.7% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $0.00 | -100.0% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $0.20 | -25.9% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $0.00 | -100.0% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $0.03 | – |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $0.12 | +100.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $0.27 | +17.4% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $0.15 | +15.4% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | -$0.33 | – |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $0.06 | – |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $0.23 | – |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $0.13 | -45.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | -$0.27 | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$0.02 | – |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | -$0.36 | – |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $0.24 | +242.9% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | -$1.01 | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | -$0.36 | – |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | -$0.03 | – |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $0.07 | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | -$3.73 | – |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | -$0.02 | – |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | -$1.28 | -953.3% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | -$0.02 | – |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | -$0.25 | – |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | -$0.10 | – |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $0.15 | +150.0% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | -$0.03 | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | -$0.41 | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | -$0.22 | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $0.06 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?